Chemically Driven Clearance of Amyloid Aggregates by Polyfunctionalized Furo[2,3- b :4,5- b ′]dipyridine–Chalcone Hybrids to Ameliorate Memory in an Alzheimer Mouse Model
Molecular Pharmaceutics · 2024
DOI: 10.1021/acs.molpharmaceut.4c00068 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2024. Verfasst von Minhae Cha und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrative Biotechnology & Translational Medicine, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon 21983, Republic of Korea. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid beta-Peptides, Disease Models, Animal, Mice, Transgenic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Korea Health Industry Development Institute, National Research Foundation of Korea, Amyloid Solution.
Themen: Demenz
Abstract (Originalsprache)
The aberrant assembly of amyloid-β (Aβ) is implicated in Alzheimer's disease (AD). Recent clinical outcomes of Aβ-targeted immunotherapy reinforce the notion that clearing Aβ burden is a potential therapeutic approach for AD. Herein, to develop drug candidates for chemically driven clearance of Aβ aggregates, we synthesized 51 novel polyfunctionalized furo[2,3-b:4,5-b']dipyridine-chalcone hybrid compounds. After conducting two types of cell-free anti-Aβ functional assays, Aβ aggregation prevention and Aβ aggregate clearance, we selected YIAD-0336, (E)-8-((1H-pyrrol-2-yl)methylene)-10-(4-chlorophenyl)-2,4-dimethyl-7,8-dihydropyrido[3',2':4,5]furo[3,2-b]quinolin-9(6H)-one, for further in vivo investigations. As YIAD-0336 exhibited a low blood-brain barrier penetration profile, it was injected along with aggregated Aβ directly into the intracerebroventricular region of ICR mice and ameliorated spatial memory in Y-maze tests. Next, YIAD-0336 was orally administered to 5XFAD transgenic mice with intravenous injections of mannitol, and YIAD-0336 significantly removed Aβ plaques from the brains of 5XFAD mice. Collectively, YIAD-0336 dissociated toxic aggregates in the mouse brain and hence alleviated cognitive deterioration. Our findings indicate that chemically driven clearance of Aβ aggregates is a promising therapeutic approach for AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Integrative Biotechnology & Translational Medicine, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon 21983, Republic of Korea.
- College of Pharmacy, Gachon University, 191 Hambakmoe-ro, Yeonsu-gu, Incheon 21936, Republic of Korea.
- Amyloid Solution, Seongnam-si 13486, Gyeonggi-do, Republic of Korea.
- Department of Psychiatry, Institute of Behavioral Science in Medicine, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
ORCID-Profile: Hye Yun Kim, Ikyon Kim, YoungSoo Kim
Förderung
- Korea Health Industry Development Institute
- National Research Foundation of Korea
- Amyloid Solution
Zitieren
APA
Cha, M., Kim, S., Jung, E., Cho, I., Park, I., Yoon, S., Ye, S., Lee, S., Kim, J., Kim, H. Y., Oh, J. H., Maeng, H. J., Kim, I., & Kim, Y. (2024). Chemically Driven Clearance of Amyloid Aggregates by Polyfunctionalized Furo[2,3- b :4,5- b ′]dipyridine–Chalcone Hybrids to Ameliorate Memory in an Alzheimer Mouse Model. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c00068
Vancouver
Cha M, Kim S, Jung E, Cho I, Park I, Yoon S, et al. Chemically Driven Clearance of Amyloid Aggregates by Polyfunctionalized Furo[2,3- b :4,5- b ′]dipyridine–Chalcone Hybrids to Ameliorate Memory in an Alzheimer Mouse Model. Molecular Pharmaceutics. 2024. doi:10.1021/acs.molpharmaceut.4c00068
BibTeX
@article{Cha2024,
author = {Cha, Minhae and Kim, Sunmi and Jung, Euijin and Cho, Illhwan and Park, InWook and Yoon, Soljee and Ye, Suhyun and Lee, Songmin and Kim, JiMin and Kim, Hye Yun and Oh, Ji-Hoon and Maeng, Han-Joo and Kim, Ikyon and Kim, YoungSoo},
title = {Chemically Driven Clearance of Amyloid Aggregates by Polyfunctionalized Furo[2,3- b :4,5- b ′]dipyridine–Chalcone Hybrids to Ameliorate Memory in an Alzheimer Mouse Model},
journal = {Molecular Pharmaceutics},
year = {2024},
doi = {10.1021/acs.molpharmaceut.4c00068}
}
EUVIMED